DK154841C - Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis - Google Patents

Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Info

Publication number
DK154841C
DK154841C DK475779A DK475779A DK154841C DK 154841 C DK154841 C DK 154841C DK 475779 A DK475779 A DK 475779A DK 475779 A DK475779 A DK 475779A DK 154841 C DK154841 C DK 154841C
Authority
DK
Denmark
Prior art keywords
membrane proteins
neisseria meningitidis
procedure
manufacturing membrane
optionally
Prior art date
Application number
DK475779A
Other languages
Danish (da)
English (en)
Other versions
DK154841B (da
DK475779A (da
Inventor
Torsten Bertil Helting
Gerhard Guthoehrlein
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK475779A publication Critical patent/DK475779A/da
Publication of DK154841B publication Critical patent/DK154841B/da
Application granted granted Critical
Publication of DK154841C publication Critical patent/DK154841C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK475779A 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis DK154841C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782848965 DE2848965A1 (de) 1978-11-11 1978-11-11 Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
DE2848965 1978-11-11

Publications (3)

Publication Number Publication Date
DK475779A DK475779A (da) 1980-05-12
DK154841B DK154841B (da) 1988-12-27
DK154841C true DK154841C (da) 1989-06-05

Family

ID=6054405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK475779A DK154841C (da) 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Country Status (9)

Country Link
EP (1) EP0011243B1 (enExample)
JP (1) JPS5566519A (enExample)
AT (1) ATE857T1 (enExample)
AU (1) AU533386B2 (enExample)
CA (1) CA1142083A (enExample)
DE (2) DE2848965A1 (enExample)
DK (1) DK154841C (enExample)
ES (1) ES485715A1 (enExample)
IL (1) IL58673A (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317811A (en) 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
WO1984002194A1 (en) * 1982-12-02 1984-06-07 Univ Rockefeller IgA BINDING ANTIBODY
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
BR9910749A (pt) 1998-05-29 2001-02-13 Chiron Corp Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma
DK2270173T3 (en) 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
RU2279889C2 (ru) 2000-01-17 2006-07-20 Чирон С.Р.Л. ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
SI2255826T1 (sl) 2002-08-02 2016-07-29 Glaxosmithkline Biologicals S.A. Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CU23313A1 (es) 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
JP5173194B2 (ja) * 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
CA2654706A1 (en) 2006-06-12 2007-12-21 Nathalie Devos Neisseria meningitidis lipooligosaccharide vaccine
US20100285069A1 (en) 2007-10-19 2010-11-11 Mario Contorni Meningococcal vaccine formulations
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
BRPI0923006A2 (pt) 2008-12-17 2016-03-08 Novartis Ag vacinas meningococicas incluindo receptor de hemoglobina
JP5867952B2 (ja) 2009-06-10 2016-02-24 ノバルティス アーゲー ベンゾナフチリジン含有ワクチン
CA2772103A1 (en) 2009-08-27 2011-03-03 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
NZ598458A (en) 2009-08-27 2014-03-28 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
AU2010302344A1 (en) 2009-09-30 2012-04-26 Novartis Ag Expression of meningococcal fhbp polypeptides
BR112012010531A2 (pt) 2009-10-27 2019-09-24 Novartis Ag "polipeptídeos de modificação meningocócica fhbp"
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
CA2784580A1 (en) 2009-12-15 2011-07-14 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
BR112012022669A2 (pt) 2010-03-10 2017-02-14 Glaxosmithkline Biologicals Sa composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina.
US20130071422A1 (en) 2010-03-18 2013-03-21 Michele Pallaoro Adjuvanted vaccines for serogroup b meningococcus
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
CA2810971C (en) 2010-09-10 2020-11-03 Novartis Ag Developments in meningococcal outer membrane vesicles
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
CA2861946A1 (en) 2012-02-02 2013-08-08 Novartis Ag Promoters for increased protein expression in meningococcus
ES2750366T3 (es) 2012-03-08 2020-03-25 Glaxosmithkline Biologicals Sa Ensayo de potencia in vitro para vacunas meningocócicas basadas en proteína
RU2644340C2 (ru) 2012-06-14 2018-02-08 Новартис Аг Вакцины для менингококка серогруппы х
WO2014037472A1 (en) 2012-09-06 2014-03-13 Novartis Ag Combination vaccines with serogroup b meningococcus and d/t/p
RU2662970C2 (ru) 2012-09-18 2018-07-31 Новартис Аг Везикулы наружной мембраны
AU2015222121B2 (en) 2014-02-28 2018-01-18 Glaxosmithkline Biologicals Sa Modified meningococcal fHbp polypeptides
AU2017321039B2 (en) 2016-09-02 2021-03-18 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
CN111148531A (zh) 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
WO2020094580A1 (en) 2018-11-06 2020-05-14 Glaxosmithkline Biologicals Sa Immunogenic compositions
EP3799884A1 (en) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Immunogenic compositions
GB202115072D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202211033D0 (en) 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process

Also Published As

Publication number Publication date
DE2962526D1 (en) 1982-05-27
JPS6350332B2 (enExample) 1988-10-07
DK154841B (da) 1988-12-27
AU533386B2 (en) 1983-11-24
DE2848965A1 (de) 1980-05-22
IL58673A0 (en) 1980-02-29
EP0011243B1 (de) 1982-04-14
ES485715A1 (es) 1980-05-16
JPS5566519A (en) 1980-05-20
EP0011243A1 (de) 1980-05-28
AU5268279A (en) 1980-05-15
DK475779A (da) 1980-05-12
IL58673A (en) 1983-02-23
CA1142083A (en) 1983-03-01
ATE857T1 (de) 1982-04-15

Similar Documents

Publication Publication Date Title
DK154841C (da) Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis
DE69423383D1 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
DE69116305D1 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
ES2127726T3 (es) Un metodo para la preparacion de hemoglobina piridoxilada.
MX165343B (es) Tratamiento de membranas permeables
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DK164628C (da) Fremgangsmaade til forbedring af ristet kaffe
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
EP0607593A3 (de) Verfahren zur Gewinnnung von Zellkulturen mit erhöhtem Gehalt an körpereigenen Zytokinen.
DE3265664D1 (en) Process for the production of a biochemical vaccine against salmonella fevers
ATE161051T1 (de) Verfahren zur herstellung aktivierter sialinsäuren
FR2620726B1 (fr) Procede de preparation d'un extrait de jasmin et extrait obtenu
ATE116989T1 (de) Verfahren zur reinigung von hemin, neues heminderivat und verfahren zur herstellung.
NO984206L (no) Fremgangsmaate for fremstilling av N-beskyttende D-prolinderivater
ATE118008T1 (de) Verfahren zur herstellung von aminomethanphosphonsäure und aminomethyl- phosphinsäuren.
ATE101393T1 (de) Phenanthridinderivate, verfahren zu ihrer herstellung und mittel zur ausfuehrung des verfahrens.
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
SU1564190A1 (ru) Способ получени препарата фотосинтетических реакционных центров, содержащих фотоактивные цитохромы
DK222887A (da) Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer
DK632187D0 (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
GB8814484D0 (en) Improved process for obtaining synthetic hides similar to natural hides by chemical treatment
JPS6410950A (en) Elimination of taste and odor of substance rich in amino acid
ATE209171T1 (de) Verfahren zur herstellung von 4,4,4- trichlorbutanol

Legal Events

Date Code Title Description
PBP Patent lapsed